Insider Trading activities of Si-bone, Inc. (SIBN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Si-bone, Inc. (SIBN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Si-bone, Inc. since year 2005. Table 2 shows the detailed insider transactions of Si-bone, Inc. since 2005. The reporting company's ticker symbol is SIBN. The reporting company's CIK number is 1459839.
The total value of stock buying since 2005 is $18,750,000.
The total value of stock sales since 2005 is $2,647,277.
The total value of stock option exercises since 2005 is $148,664.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Si-bone, Inc. (SIBN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-07 0 $0 30,609 $608,202 6,500 $26,280
2019-06 0 $0 60,775 $1,178,251 19,618 $55,979
2019-05 0 $0 23,043 $371,353 7,886 $34,067
2019-04 0 $0 22,168 $373,447 7,486 $32,338
2018-10 1,250,000 $18,750,000 0 $0 0 $0
2018-04 0 $0 6,980 $116,024 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Si-bone, Inc. insiders (SIBN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-07-18 Reckling W Carlton (CMO and VP, Medical Affairs) Sale 153 20.00 3,060
2019-07-18 Pisetsky Michael A (GC & Chief Compliance Officer) Sale 242 20.00 4,840
2019-07-18 Yerby Scott A (Chief Technology Officer) Sale 10,217 20.01 204,411
2019-07-18 Francis Laura (Chief Financial Officer) Sale 485 20.00 9,700
2019-07-18 Recupero Anthony J (Chief Commercial Officer) Sale 419 20.00 8,380
2019-07-18 Dunn Jeffrey W (Chairman, President & CEO) Sale 1,436 20.16 28,948
2019-07-17 Reckling W Carlton (CMO and VP, Medical Affairs) Sale 5,000 20.01 100,060
2019-07-17 Reckling W Carlton (CMO and VP, Medical Affairs) Option Ex 5,000 3.96 19,800
2019-07-15 Yerby Scott A (Chief Technology Officer) Sale 10,133 19.61 198,728
2019-07-08 Yerby Scott A (Chief Technology Officer) Sale 648 19.01 12,318
2019-07-02 Yerby Scott A (Chief Technology Officer) Sale 376 20.14 7,572
2019-07-01 Recupero Anthony J (Chief Commercial Officer) Sale 1,500 20.12 30,185
2019-07-01 Recupero Anthony J (Chief Commercial Officer) Option Ex 1,500 4.32 6,480
2019-06-28 Reckling W Carlton (CMO and VP, Medical Affairs) Sale 15,000 20.00 300,000
2019-06-28 Reckling W Carlton (CMO and VP, Medical Affairs) Option Ex 15,000 2.40 36,030
2019-06-28 Yerby Scott A (Chief Technology Officer) Sale 30,000 20.00 600,000
2019-06-28 Recupero Anthony J (Chief Commercial Officer) Sale 900 20.00 18,000
2019-06-28 Recupero Anthony J (Chief Commercial Officer) Option Ex 900 4.32 3,888
2019-06-25 Francis Laura (Chief Financial Officer) Sale 2,518 17.92 45,115
2019-06-25 Francis Laura (Chief Financial Officer) Option Ex 2,518 4.32 10,877
2019-06-18 Yerby Scott A (Chief Technology Officer) Sale 4,433 17.66 78,269
2019-06-17 Yerby Scott A (Chief Technology Officer) Sale 5,700 17.41 99,259
2019-06-10 Recupero Anthony J (Chief Commercial Officer) Sale 200 18.00 3,600
2019-06-10 Recupero Anthony J (Chief Commercial Officer) Option Ex 200 4.32 864
2019-06-06 Yerby Scott A (Chief Technology Officer) Sale 648 17.19 11,139
2019-06-03 Yerby Scott A (Chief Technology Officer) Sale 376 16.62 6,249
2019-06-03 Recupero Anthony J (Chief Commercial Officer) Sale 1,000 16.62 16,620
2019-06-03 Recupero Anthony J (Chief Commercial Officer) Option Ex 1,000 4.32 4,320
2019-05-28 Francis Laura (Chief Financial Officer) Sale 6,486 15.97 103,561
2019-05-28 Francis Laura (Chief Financial Officer) Option Ex 6,486 4.32 28,019
2019-05-16 Pisetsky Michael A (GC & Chief Compliance Officer) Sale 2,000 15.96 31,920
2019-05-16 Francis Laura (Chief Financial Officer) Sale 2,000 15.96 31,916
2019-05-15 Yerby Scott A (Chief Technology Officer) Sale 10,133 16.05 162,675
2019-05-08 Recupero Anthony J (Chief Commercial Officer) Sale 400 18.00 7,200
2019-05-08 Recupero Anthony J (Chief Commercial Officer) Option Ex 400 4.32 1,728
2019-05-06 Yerby Scott A (Chief Technology Officer) Sale 648 16.93 10,970
2019-05-02 Yerby Scott A (Chief Technology Officer) Sale 376 16.57 6,230
2019-05-01 Recupero Anthony J (Chief Commercial Officer) Sale 1,000 16.88 16,881
2019-05-01 Recupero Anthony J (Chief Commercial Officer) Option Ex 1,000 4.32 4,320
2019-04-26 Francis Laura (Chief Financial Officer) Option Ex 3,968 4.32 17,141
2019-04-15 Reckling W Carlton (CMO and VP, Medical Affairs) Sale 151 16.59 2,505
2019-04-15 Pisetsky Michael A (GC & Chief Compliance Officer) Sale 241 16.59 3,998
2019-04-15 Yerby Scott A (Chief Technology Officer) Sale 10,349 16.77 173,532
2019-04-15 Reiley Mark A (Director) Sale 10,000 16.95 169,460
2019-04-15 Francis Laura (Chief Financial Officer) Option Ex 2,518 4.32 10,877
2019-04-15 Recupero Anthony J (Chief Commercial Officer) Sale 1,427 16.79 23,952
2019-04-15 Recupero Anthony J (Chief Commercial Officer) Option Ex 1,000 4.32 4,320
2018-10-19 Orbimed Capital Gp V Llc (Director) Buy 200,000 15.00 3,000,000
2018-10-19 Petersen Timothy (Director) Buy 200,000 15.00 3,000,000
2018-10-19 Bonita David P (Director) Buy 200,000 15.00 3,000,000
2018-10-19 Freund John Gordon (Director) Buy 325,000 15.00 4,875,000
2018-10-19 Kaneko Yasunori (10% Owner) Buy 325,000 15.00 4,875,000
2018-04-26 Francis Laura (Chief Financial Officer) Sale 3,968 16.54 65,610
2018-04-15 Francis Laura (Chief Financial Officer) Sale 3,012 16.74 50,414

Insider trading activities including stock purchases, stock sales, and option exercises of SIBN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Si-bone, Inc. (symbol SIBN, CIK number 1459839) see the Securities and Exchange Commission (SEC) website.